journal article·2015-05-20

Synthesis and Preliminaryin VivoEvaluation of Well-Dispersed Biomimetic Nanocrystalline Apatites Labeled with Positron Emission Tomographic Imaging Agents

Benedikt Sandhöfer, Marian Meckel, José Manuel Delgado-López, Tatiana Patrício, Anna Tampieri, Frank Rösch, Michele Iafisco

Publisher page

Abstract

In recent years, biomimetic synthetic apatite nanoparticles (AP-NPs), having chemical similarity with the mineral phase of bone, have attracted a great interest in nanomedicine as potential drug carriers. To evaluate the therapeutic perspectives of AP-NPs through the mechanisms of action and organs they interact with, the noninvasive monitoring of their in vivo behavior is of paramount importance. To this aim, here the feasibility to radiolabel AP-NPs ("naked" and surface-modified with citrate to reduce their aggregation) with two positron emission tomographic (PET) imaging agents ([(18)F]NaF and (68)Ga-NO2AP(BP)) was investigated. [(18)F]NaF was used for the direct incorporation of the radioisotope into the crystal lattice, while the labeling by surface functionalization was accomplished by using (68)Ga-NO2AP(BP) (a new radio-metal chelating agent). The labeling results with both tracers were fast, straightforward, and reproducible. AP-NPs demonstrated excellent ability to bind relevant quantities of both radiotracers and good in vitro stability in clinically relevant media after the labeling. In vivo PET studies in healthy Wistar rats established that the radiolabeled AP-NPs gave significant PET signals and they were stable over the investigated time (90 min) since any tracer desorption was detected. These preliminary in vivo studies furthermore showed a clear ability of citrated versus naked AP-NPs to accumulate in different organs. Interestingly, contrary to naked AP-NPs, citrated ones, which unveiled higher colloidal stability in aqueous suspensions, were able to escape the first physiological filter, i.e., the lungs, being then accumulated in the liver and, to a lesser extent, in the spleen. The results of this work, along with the fact that AP-NPs can be also functionalized with targeting ligands, with therapeutic agents, and also with metals for a combination of different imaging modalities, make AP-NPs very encouraging materials for further investigations as theranostic agents in nanomedicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Nanoparticle-Based Drug Delivery · Titanium Alloys Microstructure and Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Nuclear Chemistry, Johannes Gutenberg-University, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany

Instituto Andaluz de Ciencias de la Tierra (IACT), (CSIC-UGR), Laboratorio de Estudios Cristalográficos, Avenida Las Palmeras 4, 18100 Armilla, Spain

Institute of Science and Technology for Ceramics (ISTEC), National Research Council (CNR), Via Granarolo 64, 48018 Faenza, Italy

Funding

European Cooperation in Science and Technology · International Campus of Excellence, University of Granada · Consejo Superior de Investigaciones Científicas

References (70)

Show source-provided references
1. Sun T. · Angew. Chem., Int. Ed. · 2014 · 53 · 1232010.1002/anie.201403036 ↗
2. Pietronave S. · J. Appl. Biomater. Biomech. · 2009 · 7 · 77
3. Gao J. · Nano Today · 2009 · 4 · 3710.1016/j.nantod.2008.10.009 ↗
4. Wang A. Z. · Annu. Rev. Med. · 2012 · 63 · 18510.1146/annurev-med-040210-162544 ↗
5. Doane T. L. · Chem. Soc. Rev. · 2012 · 41 · 288510.1039/c2cs15260f ↗
6. Iafisco M. · Small · 2013 · 9 · 383410.1002/smll.201202843 ↗
7. Hossain S. · PLoS One · 2013 · 8 · e6042810.1371/journal.pone.0060428 ↗
8. Al-Kattan A. · J. Biomater. Appl. · 2014 · 28 · 69710.1177/0885328212473510 ↗
9. Gómez-Morales J. · Prog. Cryst. Growth Charact. Mater. · 2013 · 59 · 110.1016/j.pcrysgrow.2012.11.001 ↗
10. Bose S. · Acta Biomater. · 2012 · 8 · 140110.1016/j.actbio.2011.11.017 ↗
11. Al-Kattan A. · Int. J. Pharm. · 2012 · 423 · 2610.1016/j.ijpharm.2011.07.005 ↗
12. Iafisco M. · Colloids Surf., B · 2012 · 90 · 110.1016/j.colsurfb.2011.09.033 ↗
13. Xie G. · J. Mater. Sci: Mater. Med. · 2010 · 21 · 1875
14. Cheng X. · Int. J. Nanomed. · 2007 · 2 · 667
15. Chowdhury E. H. · Expert Opin. Drug Delivery · 2007 · 4 · 19310.1517/17425247.4.3.193 ↗
16. Uskoković V. · J. Biomed. Mater. Res., Part B · 2011 · 96 · 15210.1002/jbm.b.31746 ↗
17. Chen L. · Nanotechnology · 2011 · 22 · 10570810.1088/0957-4484/22/10/105708 ↗
18. Turkez H. · J. Appl. Toxicol. · 2014 · 34 · 37310.1002/jat.2958 ↗
19. Zhao X. · Arch. Toxicol. · 2013 · 87 · 103710.1007/s00204-012-0827-1 ↗
20. Zhao X. · Small · 2013 · 9 · 173410.1002/smll.201200639 ↗
21. Jauregui-Osoro M. · Dalton Trans. · 2011 · 40 · 622610.1039/c0dt01618g ↗
22. Ong H. · J. Nanopart. Res. · 2008 · 10 · 14110.1007/s11051-007-9239-1 ↗
23. Liu Y. · Biomaterials · 2014 · 35 · 334810.1016/j.biomaterials.2013.12.064 ↗
24. Ignjatović N. · Mater. Sci. Eng., C · 2014 · 43 · 43910.1016/j.msec.2014.07.046 ↗
25. Stockhofe K. · Pharmaceuticals · 2014 · 7 · 39210.3390/ph7040392 ↗
26. Loudos G. · Eur. J. Radiol. · 2011 · 78 · 28710.1016/j.ejrad.2010.06.025 ↗
27. Ting G. · Anticancer Res. · 2009 · 29 · 4107
28. Lee D.-E. · Chem. Soc. Rev. · 2012 · 41 · 265610.1039/C2CS15261D ↗
29. Welch M. J. · J. Nucl. Med. · 2009 · 50 · 174310.2967/jnumed.109.061846 ↗
30. Sun X. · Acc. Chem. Res. · 2015 · 48 · 28610.1021/ar500362y ↗
31. Xing Y. · Theranostics · 2014 · 4 · 29010.7150/thno.7341 ↗
32. Czernin J. · J. Nucl. Med. · 2010 · 51 · 182610.2967/jnumed.110.077933 ↗
33. Le Bars D. · J. Fluorine Chem. · 2006 · 127 · 148810.1016/j.jfluchem.2006.09.015 ↗
34. Holub J. · Contrast Media Mol. Imaging · 2015 · 10 · 12210.1002/cmmi.1606 ↗
35. Patterson A. L. · Phys. Rev. · 1939 · 56 · 97810.1103/PhysRev.56.978 ↗
36. Zhernosekov K. P. · J. Nucl. Med. · 2007 · 48 · 174110.2967/jnumed.107.040378 ↗
37. Fellner M. · Radiochim. Acta · 2011 · 99 · 4310.1524/ract.2011.1791 ↗
38. Koutsopoulos S. · J. Biomed. Mater. Res., Part A · 2002 · 62 · 60010.1002/jbm.10280 ↗
39. Delgado-López J. M. · Acta Biomater. · 2012 · 8 · 349110.1016/j.actbio.2012.04.046 ↗
40. Rey C. · Prog. Cryst. Growth Charact. Mater. · 2014 · 60 · 6310.1016/j.pcrysgrow.2014.09.005 ↗
41. Drouet C. · Mater. Sci. Eng., C · 2008 · 28 · 154410.1016/j.msec.2008.04.011 ↗
42. Lee H. J. · Chem. Mater. · 2006 · 18 · 511110.1021/cm061139x ↗
43. Ashokan A. · Biomaterials · 2010 · 31 · 260610.1016/j.biomaterials.2009.11.113 ↗
44. Han Y. · J. Nanopart. Res. · 2009 · 11 · 123510.1007/s11051-008-9507-8 ↗
45. Liou S.-C. · J. Biomed. Mater. Res., Part B · 2005 · 73 · 11710.1002/jbm.b.30193 ↗
46. Lopez-Macipe A. · Adv. Mater. · 1998 · 10 · 4910.1002/(SICI)1521-4095(199801)10:1<49::AID-ADMA49>3.0.CO;2-R ↗
47. Li C. · J. Colloid Interface Sci. · 2011 · 360 · 34110.1016/j.jcis.2011.04.059 ↗
48. Hu Y.-Y. · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 2242510.1073/pnas.1009219107 ↗
49. Xie B. · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 2236910.1073/pnas.1017493108 ↗
50. Iafisco M. · CrystEngComm · 2015 · 17 · 50710.1039/C4CE01415D ↗
51. Jin X. · J. Colloid Interface Sci. · 2015 · 443 · 12510.1016/j.jcis.2014.12.010 ↗
52. Leeuwenburgh S. C. G. · Acta Biomater. · 2010 · 6 · 83610.1016/j.actbio.2009.09.005 ↗
53. Müller K. H. · Biomaterials · 2014 · 35 · 107410.1016/j.biomaterials.2013.10.041 ↗
54. López-Macipe A. · J. Colloid Interface Sci. · 1998 · 200 · 11410.1006/jcis.1997.5343 ↗
55. Misra D. N. · Colloids Surf., A · 1998 · 141 · 17310.1016/S0927-7757(98)00332-X ↗
56. Skwarek E. · J. Radioanal. Nucl. Chem. · 2014 · 299 · 202710.1007/s10967-013-2825-z ↗
57. Tanizawa Y. · J. Chem. Soc., Faraday Trans. · 1990 · 86 · 402510.1039/ft9908604025 ↗
58. Wakamura M. · Colloids Surf., A · 2000 · 164 · 29710.1016/S0927-7757(99)00384-2 ↗
59. Fani M. · Contrast Media Mol. Imaging · 2008 · 3 · 5310.1002/cmmi.232 ↗
60. Brunetti A. · Nucl. Med. Biol. · 1988 · 15 · 665
61. Green M. A. · Int. J. Radiat. Appl. Instrum., Part B · 1989 · 16 · 43510.1016/0883-2897(89)90053-6 ↗
62. Pascaud P. · J. Mater. Sci: Mater. Med. · 2014 · 25 · 2373
63. Langmuir I. · J. Am. Chem. Soc. · 1918 · 40 · 136110.1021/ja02242a004 ↗
64. Jaroniec M. · Surf. Sci. · 1975 · 50 · 55310.1016/0039-6028(75)90044-8 ↗
65. Sips R. · J. Chem. Phys. · 1948 · 16 · 49010.1063/1.1746922 ↗
66. Rill C. · Langmuir · 2009 · 25 · 229410.1021/la803562e ↗
67. Sternitzke V. · Environ. Sci. Technol. · 2012 · 46 · 80210.1021/es202750t ↗
68. Demoy M. · Pharm. Res. · 1999 · 16 · 3710.1023/A:1018858409737 ↗
69. Rojas S. · Mol. Pharmaceutics · 2012 · 9 · 354310.1021/mp300382n ↗
70. Nie S. · Nanomedicine (London, U. K.) · 2010 · 5 · 52310.2217/nnm.10.23 ↗